Tanguler Tolga
SEC CIK 1849458 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Commercial Off | 34.3K | — | $8.93M | 36 | 2022-02-01 | 2026-03-04 |
Most active insiders at ALNY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| 2 | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| 3 | Garg Pushkal | EVP Chief R, D | — | $8.12M |
| 4 | Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| 5 | Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| 6 | McLaughlin Melissa | CHRO | — | $1.27M |
| 7 | PYOTT DAVID E I | Dir | — | $1.15M |
| 8 | Reitan Colleen F | Dir | — | — |
| 9 | Sigal Charles Elliott | Dir | — | — |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-06 | 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $323.08 | -2,309 | 34.3K | -6% | -$746.0K |
| DM | 2026-03-04 | 2026-03-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $327.65 | -1,598 | 38.2K | -4% | -$523.6K |
| D | 2026-03-04 | 2026-03-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +4,769 | 38.2K | +14% | $0 |
| D | 2026-03-02 | 2026-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +1,666 | 33.4K | +5% | $0 |
| 2026-02-17 | 2026-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $310.08 | -1,959 | 31.8K | -6% | -$607.4K | |
| 2026-02-17 | 2026-02-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +4,000 | 33.7K | +13% | $0 | |
| 2026-01-14 | 2026-01-11 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,800 | 31.2K | +14% | $0 | |
| M | 2026-01-14 | 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $362.87 | -1,510 | 31.2K | -5% | -$547.9K |
| M | 2025-10-03 | 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $452.05 | -1,405 | 27.4K | -5% | -$635.1K |
| 2025-10-03 | 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +2,851 | 28.8K | +11% | $0 | |
| M | 2025-09-02 | 2025-08-29 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $448.37 | -3,474 | 26.0K | -12% | -$1.56M |
| 2025-08-19 | 2025-08-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +2,851 | 30.9K | +10% | $0 | |
| M | 2025-08-19 | 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $453.27 | -1,396 | 29.5K | -5% | -$632.8K |
| DM | 2025-03-05 | 2025-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $243.78 | -471 | 28.4K | -2% | -$114.8K |
| D | 2025-03-05 | 2025-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +14.1K | 28.5K | +99% | $0 |
| DM | 2025-03-03 | 2025-02-28 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale+OE | $241.68 | -513 | 14.8K | -3% | -$124.0K |
| D | 2025-03-03 | 2025-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +1,667 | 14.9K | +13% | $0 |
| M | 2024-11-27 | 2024-11-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $250.98 | -1,469 | 13.2K | -10% | -$368.7K |
| 2024-11-27 | 2024-11-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,000 | 14.7K | +26% | $0 | |
| M | 2024-06-26 | 2024-06-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $231.00 | -1,605 | 13.2K | -11% | -$370.7K |
| 2024-06-26 | 2024-06-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,278 | 13.3K | +33% | $0 | |
| D | 2024-03-05 | 2024-03-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +4,751 | 9,987 | +91% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale+OE | $155.30 | -501 | 5,237 | -9% | -$77.8K |
| D | 2024-02-29 | 2024-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +1,667 | 5,737 | +41% | $0 |
| M | 2024-02-20 | 2024-02-16 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $148.06 | -1,009 | 4,070 | -20% | -$149.4K |
| 2024-02-20 | 2024-02-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,278 | 5,079 | +182% | $0 | |
| M | 2023-04-28 | 2023-04-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $194.59 | -1,476 | 3,155 | -32% | -$287.2K |
| 2023-04-28 | 2023-04-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,277 | 3,277 | New | $0 | |
| DM | 2023-02-03 | 2023-02-02+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale+OE | $230.19 | -5,025 | 2,246 | -69% | -$1.16M |
| D | 2023-02-03 | 2023-02-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +5,025 | 5,025 | New | $0 |
| 2022-08-05 | 2022-08-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,629 | 5,383 | +207% | $0 | |
| M | 2022-08-05 | 2022-08-03+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $214.18 | -3,595 | 0 | -100% | -$770.0K |
| M | 2022-08-05 | 2022-08-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | F - Tax | $191.73 | -1,788 | 1,841 | -49% | -$342.8K |
| 2022-07-07 | 2022-07-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $150.00 | -1,754 | 1,754 | -50% | -$263.1K | |
| D | 2022-02-03 | 2022-02-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +5,026 | 5,026 | New | $0 |
| D | 2022-02-03 | 2022-02-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Off | F - Tax | $144.67 | -1,518 | 3,508 | -30% | -$219.6K |
Purchase Sale Sale after option exercise All abbreviations